Concepedia

Author

Ravinder N. Maini

Kennedy Center

Also Known As

Maini, R. N., R MAINI, R Maini, R N MAINI, R N Maini, R. Maini, R. N. MAINI, R. N. Maini, R.N Maini, R.N. MAINI

341

Publications

40.3K

Citations

85

H-Index

111

Concepts

All Affiliations

Kennedy CenterCharing Cross HospitalBritish Society for RheumatologyInstitute of RheumatologyImperial College London
RN

About

Ravinder N. Maini is an author at Kennedy Center specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

37

72

10.9K

2

Allergy

16

21

1.9K

3

Engineering

1

1

18

4

Public Health

1

1

15

5

Biochemistry

1

1

18

Ravinder N. Maini

×

157

Publications

31.8K

Citations

72

H-Index

YearCitations

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair,

New England Journal of Medicine

2000

3K

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld,

The Lancet

1999

2.3K

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

Michael J. Elliott, Ravinder N. Maini, Marc Feldmann,

The Lancet

1994

1.7K

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

Ravinder N. Maini, Ferdinand C. Breedveld, Joachim R. Kalden,

Arthritis & Rheumatism

1998

1.6K

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European community

Claudio Vitali, Stefano Bombardieri, Haralampos Μ. Moutsopoulos,

Arthritis & Rheumatism

1993

1.4K

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

E. William St. Clair, Désirée van der Heijde, Josef S Smolen,

Arthritis & Rheumatism

2004

1.2K

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

Michael J. Elliott, Ravinder N. Maini, Marc Feldmann,

Arthritis & Rheumatism

1993

1K

Range of antinuclear antibodies in “healthy” individuals

Eng M. Tan, T. E. W. Feltkamp, Josef S Smolen,

Arthritis & Rheumatism

1997

858

Double‐blind randomized controlled clinical trial of the interleukin‐6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

Ravinder N. Maini, Peter C. Taylor, Jacek Szechiński,

Arthritis & Rheumatism

2006

789

Mesenchymal precursor cells in the blood of normal individuals

Nathan J. Zvaifler, L. Marinova‐Mutafchieva, Gill Adams,

Arthritis Research & Therapy

2000

745

Page 1